Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion
Xuemei Gu(Shanghai Eighth People Hospital), Ping Gao(University of Science and Technology of China), Mengqiu Yuan(University of Science and Technology of China), Chuxu Zhu(South China University of Technology), Yingxuan Yu(South China University of Technology), Zhenhua Bian(South China University of Technology), Pinggen Zhang(University of Science and Technology of China), Linchong Sun(Guangdong Academy of Medical Sciences), Caixia Suo(Guangzhou First People's Hospital), Jin‐Zhi Du(South China University of Technology), Haoran Wei(Xinjiang Agricultural University), Liang Chen(Henan Medical University), Huafeng Zhang(University of Science and Technology of China), Kai Yan(Guangdong Academy of Medical Sciences), Zhikun Li(South China University of Technology), Shengqi Shen(University of Science and Technology of China)
Cited by 73
Related Papers
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
Metabolic reprogramming and epigenetic modifications on the path to cancer
|Protein & Cell|2021|737
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
|Cancer Cell|2006|451
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
|Cell Research|2015|316
ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1
|Nature Cancer|2021|203